# Mettler Toledo International Inc/: Form 10-Q for the period ended Sep 30, 2015

- Company: [Mettler Toledo International Inc/](/companies/mtd.md) (CIK 1037646)
- Form: 10-Q
- Filed: 2015-11-06
- Accepted by EDGAR: Nov 6, 2015, 09:03 ET
- Period: 2015-09-30
- Accession: 0001037646-15-000034
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1037646/000103764615000034/mtd10q93015.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1037646/000103764615000034/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2015-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2015-07-01 to 2015-09-30 | $604.2m | us-gaap:Revenues |
| Revenue | 9 months, 2015-01-01 to 2015-09-30 | $1.72bn | us-gaap:Revenues |
| Cost of revenue | 3 months, 2015-07-01 to 2015-09-30 | $188.7m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months, 2015-01-01 to 2015-09-30 | $536.5m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2015-07-01 to 2015-09-30 | $339.5m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2015-01-01 to 2015-09-30 | $961.2m | us-gaap:GrossProfit |
| Research and development | 3 months, 2015-07-01 to 2015-09-30 | $29.7m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2015-01-01 to 2015-09-30 | $88.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2015-07-01 to 2015-09-30 | $175.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2015-01-01 to 2015-09-30 | $523.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months, 2015-07-01 to 2015-09-30 | $7.0m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2015-01-01 to 2015-09-30 | $20.7m | us-gaap:InterestExpense |
| Income tax | 3 months, 2015-07-01 to 2015-09-30 | $28.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2015-01-01 to 2015-09-30 | $72.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2015-07-01 to 2015-09-30 | $88.9m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2015-01-01 to 2015-09-30 | $229.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2015-07-01 to 2015-09-30 | $3.16 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2015-01-01 to 2015-09-30 | $8.07 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2015-07-01 to 2015-09-30 | $3.23 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2015-01-01 to 2015-09-30 | $8.24 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2015-07-01 to 2015-09-30 | 28,113,287 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2015-01-01 to 2015-09-30 | 28,443,478 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2015-01-01 to 2015-09-30 | $289.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2015-01-01 to 2015-09-30 | $56.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months, 2015-01-01 to 2015-09-30 | $371.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2015-09-30 | $123.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2015-09-30 | $868.3m | us-gaap:AssetsCurrent |
| Total assets | at 2015-09-30 | $2.05bn | us-gaap:Assets |
| Current liabilities | at 2015-09-30 | $593.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2015-09-30 | $1.47bn | us-gaap:Liabilities |
| Long-term debt | at 2015-09-30 | $601.7m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2015-09-30 | $586.4m | us-gaap:StockholdersEquity |
| Shares outstanding | at 2015-09-30 | 27,356,838 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 31,692 characters.

*The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the Unaudited Interim Consolidated Financial Statements included herein.*

### General

Our interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. Operating results for the three and nine months ended September 30, 2015 are not necessarily indicative of the results to be expected for the full year ending December 31, 2015.

Changes in local currency exclude the effect of currency exchange rate fluctuations. Local currency amounts are determined by translating current and previous year consolidated financial information at an index utilizing historical currency exchange rates. We believe local currency information provides a helpful assessment of business performance and a useful measure of results between periods. We do not, nor do we suggest that investors should, consider such non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. We present non-GAAP financial measures in reporting our financial results to provide investors with an additional analytical tool to evaluate our operating results.

### Results of Operations – Consolidated

The following tables set forth certain items from our interim consolidated statements of operations for the three and nine month periods ended September 30, 2015 and 2014 (amounts in thousands).

|  | Three months ended September 30, 2015 (unaudited)% |  | 2014 (unaudited)% |  | Nine months ended September 30, 2015 (unaudited)% |  | 2014 (unaudited)% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net sales | $604,154 | 100.0 | $629,100 | 100.0 | $1,721,912 | 100.0 | $1,788,555 | 100.0 |
| Cost of sales | 264,625 | 43.8 | 285,549 | 45.4 | 760,666 | 44.2 | 824,187 | 46.1 |
| Gross profit | 339,529 | 56.2 | 343,551 | 54.6 | 961,246 | 55.8 | 964,368 | 53.9 |
| Research and development | 29,711 | 4.9 | 30,352 | 4.8 | 87,966 | 5.1 | 91,974 | 5.1 |
| Selling, general and administrative | 175,546 | 29.1 | 186,499 | 29.6 | 523,392 | 30.4 | 541,793 | 30.3 |
| Amortization | 7,767 | 1.3 | 7,198 | 1.1 | 22,929 | 1.3 | 21,575 | 1.2 |
| Interest expense | 7,029 | 1.1 | 5,991 | 1.0 | 20,696 | 1.2 | 17,613 | 1.0 |
| Restructuring charges | 2,561 | 0.4 | 1,050 | 0.2 | 5,188 | 0.3 | 4,447 | 0.2 |
| Other charges (income), net | (8) | — | 625 | 0.1 | (858) | — | 1,348 | 0.1 |
| Earnings before taxes | 116,923 | 19.4 | 111,836 | 17.8 | 301,933 | 17.5 | 285,618 | 16.0 |
| Provision for taxes | 28,062 | 4.7 | 26,840 | 4.3 | 72,464 | 4.2 | 68,549 | 3.9 |
| Net earnings | $88,861 | 14.7 | $84,996 | 13.5 | $229,469 | 13.3 | $217,069 | 12.1 |

#### Net sales

Net sales were $604.2 million and $629.1 million for the three months ended September 30, 2015 and 2014, respectively, and $1.722 billion and $1.789 billion for the nine months ended September 30, 2015 and 2014. This represents a decrease of 4% in U.S. dollars for both the three and nine months ended September 30, 2015. Excluding the effect of currency exchange rate fluctuations, or in local currencies, net sales increased 3% and 4% for the three and nine months ended September 30, 2015, as compared to prior year comparable periods. Currency exchange rate fluctuations negatively impacted net sales as most of our non-U.S. dollar trading currencies, especially the euro, have weakened against the U.S. dollar. While market conditions remain stable in most parts of the world, we see unfavorable market conditions in China, Russia and Brazil, where customer investments have slowed due to a variety of economic factors. We remain cautious about our sales outlook as the timing of a market stabilization or recovery in these three countries remains uncertain.

Net sales by geographic destination for the three and nine months ended September 30, 2015 in U.S. dollars increased in the Americas 8% and 6%, in Europe decreased 13% for both periods, and in Asia/Rest of World decreased 8% and 4%, respectively. Our net sales by geographic destination for the three and nine months ended September 30, 2015 in local currencies increased in the Americas 10% and 7%, in Europe 1% and 3%, and in Asia/Rest of World decreased 1% and increased 1%, respectively. Net sales were impacted by significant sales declines in China, Russia and Brazil. A discussion of sales by operating segment is included below.

As described in Note 16 to our consolidated financial statements for the year ended December 31, 2014, our net sales comprise product sales of precision instruments and related services. Service revenues are primarily derived from repair and other services, including regulatory compliance qualification, calibration, certification, preventative maintenance and spare parts.

Net sales of products decreased 4% in U.S. dollars and increased 3% in local currencies for the three months ended September 30, 2015 and decreased 3% in U.S. dollars and increased 4% local currencies for the nine months ended September 30, 2015, compared to the corresponding periods in 2014. Service revenue (including spare parts) decreased by 4% in U.S. dollars and increased 5% in local currencies for the three months ended September 30, 2015 and decreased 5% in U.S. dollars and increased 4% in local currencies for the nine months ended September 30, 2015, compared to the corresponding periods in 2014.

Net sales of our laboratory-related products, which represented approximately 48% of our total net sales decreased 1% in U.S. dollars and increased 7% in local currencies for both the three and nine months ended September 30, 2015. The local currency increase in net sales of our laboratory-related products for the three and nine months ended September 30, 2015 was driven by strong volume and favorable price realization in most product categories, including strong growth in pipettes, and laboratory balances for the three month period. These results were offset in part by significant sales volume declines in Brazil and Russia.

Net sales of our industrial-related products, which represented approximately 43% of our total net sales decreased 8% in U.S. dollars and 1% in local currencies for the three months ended September 30, 2015, and decreased 7% in U.S. dollars and were flat in local currencies for the nine months ended September 30, 2015, compared to the corresponding prior year periods. The decrease in local currency net sales of our industrial-related products for the three and nine months ended September 30, 2015 includes significant sales volume declines of industrial-related products in China, Russia and Brazil offset in part by strong growth in the United States primarily due to increased volume.

Net sales in our food retailing products, which represented approximately 9% of our total net sales, were flat in U.S. dollars and increased 7% in local currencies for the three months ended September 30, 2015, and decreased 2% in U.S. dollars and increased 6% in local currencies for the nine months ended September 30, 2015, compared to the corresponding prior year periods. The increase in net sales in local currencies of our food retailing products for the three months ended September 30, 2015 is driven by strong project activity in the Americas offset in part by reduced net sales in Europe.

#### Gross profit

Gross profit as a percentage of net sales was 56.2% and 54.6% for the three months ended September 30, 2015 and 2014, respectively, and 55.8% and 53.9% for the nine months ended September 30, 2015 and 2014, respectively.

Gross profit as a percentage of net sales for products was 59.8% and 57.8% for the three months ended September 30, 2015 and 2014, respectively, and 59.7% and 57.5% for the nine months ended September 30, 2015 and 2014, respectively.

Gross profit as a percentage of net sales for services (including spare parts) was 43.6% and 43.5% for the three months ended September 30, 2015 and 2014, respectively, and 42.5% and 42.0% for the nine months ended September 30, 2015 and 2014, respectively.

The increase in gross profit as a percentage of net sales for the three and nine months ended September 30, 2015 includes the benefit of hedging gains and currency translation, favorable price realization, increased sales volume, and reduced material costs, offset in part by investments in our field service organization.

#### Research and development and selling, general and administrative expenses

Research and development expenses as a percentage of net sales was 4.9% and 4.8% for the three months ended September 30, 2015 and 2014, respectively, and 5.1% for both the nine months ended September 30, 2015 and 2014. Research and development expenses decreased 2% in U.S. dollars and increased 3% in local currencies for the three months ended September 30, 2015, and decreased 4% in U.S. dollars and increased 1% in local currencies for the nine months ended September 30, 2015, respectively, compared to the corresponding periods in 2014, relating to the timing of research and development project activity.

Selling, general and administrative expenses as a percentage of net sales were 29.1% and 29.6% for the three months ended September 30, 2015 and 2014, respectively, and were 30.4% and 30.3% for the nine months ended September 30, 2015 and 2014. Selling, general and administrative expenses decreased 6% in U.S. dollars and increased 1% in local currencies for the three months ended September 30, 2015, and decreased 3% in U.S. dollars and increased 3% in local currencies for the nine months ended September 30, 2015, compared to the corresponding periods in 2014. The increase includes additional investments in our field sales organization and higher employee benefit costs, offset in part by lower cash incentive expense and benefits from our cost savings programs during the three months ended September 30, 2015.

#### Amortization, interest expense, other charges (income), net and taxes

Amortization expense was $7.8 million and $7.2 million for the three months ended September 30, 2015 and 2014, respectively, and $22.9 million and $21.6 million for the nine months ended September 30, 2015 and 2014, respectively.

Interest expense was $7.0 million and $6.0 million for the three months ended September 30, 2015 and 2014, respectively, and $20.7 million and $17.6 million for the nine months ended September 30, 2015 and 2014, respectively. The increase in interest expense for the three and nine month periods ended September 30, 2015 is primarily a result of an increase in average borrowings.

Other charges (income), net consist primarily of (gains) losses from foreign currency transactions and hedging activity, interest income and other items.

The provision for taxes is based upon using our projected annual effective tax rate of 24% for the three and nine months periods ended September 30, 2015 and 2014. Our consolidated income tax rate is lower than the U.S. statutory rate primarily because of benefits from lower-taxed non-U.S. operations. The most significant of these lower-taxed operations are in Switzerland and China.

### Results of Operations – by Operating Segment

The following is a discussion of the financial results of our operating segments. We currently have five reportable segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. A more detailed description of these segments is outlined in Note 16 to our consolidated financial statements for the year ended December 31, 2014.

#### U.S. Operations (amounts in thousands)

|  | Three months ended September 30, |  | Nine months ended September 30, |  |
| --- | ---: | ---: | ---: | ---: |
|  | 2015 | 2014% | 2015 | 2014% |
| Total net sales | $238,934 | $216,299 10% | $661,636 | $615,559 7% |
| Net sales to external customers | $217,713 | $196,241 11% | $599,283 | $553,590 8% |
| Segment profit | $40,529 | $30,695 32% | $101,719 | $84,715 20% |

Total net sales increased 10% and 7% for the three and nine months ended September 30, 2015 compared with the corresponding periods in 2014. Net sales to external customers increased 11% and 8% for the three and nine months ended September 30, 2015, respectively. The increase in total net sales and net sales to external customers for the three months ended September 30, 2015 reflects strong sales growth in most product categories.

Segment profit increased $9.8 million and $17.0 million for the three and nine months ended September 30, 2015, respectively, compared to the corresponding periods in 2014. The increase in segment profit for the three months ended September 30, 2015 primarily related to increased sales and benefits from our cost savings programs, offset in part by increased sales and service investments.

#### Swiss Operations (amounts in thousands)

|  | Three months ended September 30, 2015 | 2014 | %1) | Nine months ended September 30, 2015 | 2014 | %1) |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Total net sales | $140,063 | $147,919 | (5)% | $406,323 | $431,454 | (6)% |
| Net sales to external customers | $32,867 | $35,375 | (7)% | $97,325 | $102,522 | (5)% |
| Segment profit | $39,772 | $35,924 | 11% | $109,996 | $100,069 | 10% |

1\) Represents U.S. dollar growth for net sales and segment profit.

Total net sales decreased 5% in U.S. dollars and was flat in local currency for the three months ended September 30, 2015, compared to the corresponding periods in 2014, and decreased 6% in U.S. dollars and 1% in local currency for the nine months ended September 30, 2015. Net sales to external customers decreased 7% in U.S. dollars and 3% in local currency for the three months ended September 30, 2015 and decreased 5% in U.S. dollars and 1% in local currency for the nine months ended September 30, 2015, compared to the corresponding periods in 2014. The decrease in local currency net sales to external customers for the three month period ended September 30, 2015 includes volume declines in industrial-related products related to soft market conditions, offset in part by growth in our laboratory-related products.

Segment profit increased $3.8 million and $9.9 million for the three and nine month periods ended September 30, 2015, respectively, compared to the corresponding periods in 2014. Segment profit includes the benefit of currency hedging, the impact of favorable inter-segment price realization and reduced material costs, offset in part by unfavorable foreign currency translation.

#### Western European Operations (amounts in thousands)

|  | Three months ended September 30, 2015 | 2014 | %1) | Nine months ended September 30, 2015 | 2014 | %1) |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Total net sales | $183,018 | $206,165 | (11)% | $530,137 | $593,122 | (11)% |
| Net sales to external customers | $150,523 | $174,089 | (14)% | $442,742 | $504,172 | (12)% |
| Segment profit | $26,789 | $29,612 | (10)% | $70,476 | $74,173 | (5)% |

1\) Represents U.S. dollar growth for net sales and segment profit.

Total net sales decreased 11% in U.S. dollars and increased 4% in local currencies for the three months ended September 30, 2015 and decreased 11% in U.S. dollars and increased 7% in local currencies for the nine months ended September 30, 2015, compared to the corresponding periods in 2014. Net sales to external customers decreased 14% in U.S. dollars and increased 2% in local currencies for the three months ended September 30, 2015, and decreased 12% in U.S. dollars and increased 6% in local currencies for the nine months ended September 30, 2015, compared to the corresponding periods in 2014. Total net sales and net sales to external customers for the three and nine months ended September 30, 2015 includes strong growth across most laboratory-related products due to volume increases and favorable price realization, offset in part by a decline in product inspection for the three months ended September 30, 2015.

Segment profit decreased $2.8 million and $3.7 million for the three and nine month periods ended September 30, 2015, respectively, compared to the corresponding periods in 2014 primarily due to unfavorable foreign currency translation and increased sales and service investments, offset in part by increased total net sales in local currencies.

#### Chinese Operations (amounts in thousands)

|  | Three months ended September 30, 2015 | 2014 | %1) | Nine months ended September 30, 2015 | 2014 | %1) |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Total net sales | $146,215 | $149,323 | (2)% | $412,431 | $413,808 | 0% |
| Net sales to external customers | $96,716 | $107,907 | (10)% | $274,178 | $299,450 | (8)% |
| Segment profit | $41,665 | $43,472 | (4)% | $111,080 | $113,756 | (2)% |

1\) Represents U.S. dollar growth for net sales and segment profit.

Total net sales decreased 2% in U.S. dollars and was flat in local currency for the three months ended September 30, 2015 and was flat in both U.S. dollars and local currency for the nine months ended September 30, 2015, compared to the corresponding periods in 2014. Net sales to external customers decreased 10% in U.S. dollars and 9% in local currency for the three months ended September 30, 2015 and decreased 8% in both U.S. dollars and local currency during the nine months ended September 30, 2015, compared to the corresponding periods in 2014. The decrease in net sales to external customers during the three and nine months ended September 30, 2015 reflects a significant sales volume decline in industrial-related products offset in part by growth in laboratory-related products and food retailing. Net sales to external customers in local currency for our industrial-related products decreased 19% for both the three and nine months ended September 30, 2015.

Segment profit decreased $1.8 million and $2.7 million for the three and nine month periods ended September 30, 2015, respectively, compared to the corresponding periods in 2014. The decrease in segment profit for the three and nine months ended September 30, 2015 includes a reduction in net sales to external customers, and increased sales and service investments, offset in part by favorable price realization and favorable business mix.

#### Other (amounts in thousands)

|  | Three months ended September 30, 2015 | 2014 | %1) | Nine months ended September 30, 2015 | 2014 | %1) |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Total net sales | $108,349 | $117,352 | (8)% | $313,343 | $333,767 | (6)% |
| Net sales to external customers | $106,335 | $115,488 | (8)% | $308,384 | $328,821 | (6)% |
| Segment profit | $13,400 | $13,148 | 2% | $32,372 | $33,236 | (3)% |

1\) Represents U.S. dollar growth (decline) for net sales and segment profit.

Total net sales and net sales to external customers decreased 8% in U.S. dollars and increased 7% in local currencies for the three months ended September 30, 2015 and decreased 6% in U.S. dollars and increased 5% in local currencies for the nine months ended September 30, 2015 compared to the corresponding periods in 2014. The increase in local currency total net sales and net sales to external customers includes strong volume growth and increased price realization in several countries, offset in part by a significant sales volume declines in Russia and Brazil.

Segment profit increased $0.3 million and decreased $0.9 million for the three and nine months ended September 30, 2015, respectively, compared to the corresponding periods in 2014. The increase in segment profit for the three months ended September 30, 2015 includes increased local currency sales offset by unfavorable currency translation and increased sales and service investments.

### Liquidity and Capital Resources

Liquidity is our ability to generate sufficient cash flows from operating activities to meet our obligations and commitments. In addition, liquidity includes the ability to obtain appropriate financing. Currently, our financing requirements are primarily driven by working capital requirements, capital expenditures, share repurchases and acquisitions.

Cash provided by operating activities totaled $289.8 million during the nine months ended September 30, 2015, compared to $278.2 million in the corresponding period in 2014. The increase in 2015 includes higher net earnings and the timing of tax payments in the prior year, offset in part by the timing of accounts receivables collections in the prior year and increased cash incentive payments of approximately $14 million.

Capital expenditures are made primarily for investments in information systems and technology, machinery, equipment and the purchase and expansion of facilities. Our capital expenditures totaled $56.8 million for the nine months ended September 30, 2015 compared to $61.4 million in the corresponding period in 2014.

We continue to explore potential acquisitions. In connection with any acquisition, we may incur additional indebtedness. In September 2015, we consummated acquisitions totaling $16.6 million, including the acquisition of a real-time monitoring water purity technology for an estimated aggregate purchase price of $14.7 million that will be integrated into our process analytics product offering. We may be required to pay additional cash consideration related to an earn-out period. Goodwill recorded in connection with the acquisition totaled $8.7 million, which is included in the our U.S. Operations segment. We also recorded $6.8 million of identified intangibles primarily pertaining to technology in connection with the acquisitions, which will be amortized on a straight-line basis over 10 years.

We plan to repatriate earnings from China, Switzerland, Germany, the United Kingdom and certain other countries in future years and expect the only additional cost associated with the repatriation of such earnings outside the United States will be withholding taxes. All other undistributed earnings are considered to be permanently reinvested. As of September 30, 2015, we have an immaterial amount of cash and cash equivalents outside the United States where undistributed earnings are considered permanently reinvested. Accordingly, we believe the tax impact associated with repatriating our undistributed foreign earnings will not have a material effect on our liquidity.

#### Senior Notes and Credit Facility Agreement

Our debt consisted of the following at September 30, 2015:

|  | September 30, 2015 U.S. Dollar | Other Principal Trading Currencies | Total |
| --- | ---: | ---: | ---: |
| 3.67% $50 million Senior Notes due December 17, 2022 | 50,000 | — | 50,000 |
| 4.10% $50 million Senior Notes due September 19, 2023 | 50,000 | — | 50,000 |
| 3.84% $125 million Senior Notes due September 19, 2024 | 125,000 | — | 125,000 |
| 4.24% $125 million Senior Notes due June 25, 2025 | 125,000 | — | 125,000 |
| 1.47% EUR 125m Senior Notes due July 17, 2030 | — | 139,962 | 139,962 |
| $800 million Credit Agreement, interest at LIBOR plus 75 basis points | 100,000 | 11,769 | 111,769 |
| Other local arrangements | 283 | 20,778 | 21,061 |
| Total debt | 450,283 | 172,509 | 622,792 |
| Less: current portion | (283) | (20,778) | (21,061) |
| Total long-term debt | $450,000 | $151,731 | $601,731 |

As of September 30, 2015, we had $683.4 million available under our credit agreement. Changes in exchange rates between the currencies in which we generate cash flows and the currencies in which our borrowings are denominated affect our liquidity. In addition, because we borrow in a variety of currencies, our debt balances fluctuate due to changes in exchange rates.

We currently believe that cash flow from operating activities, together with liquidity available under our credit facility and local working capital facilities, will be sufficient to fund currently anticipated working capital needs and capital spending requirements for at least the foreseeable future.

#### Share Repurchase Program

As of September 30, 2015, we had $107.2 million of remaining availability under the Company's share repurchase program. In November 2015, the Company's Board of Directors authorized an additional $1.5 billion to the share repurchase program. The share repurchases are expected to be funded from cash balances, borrowings and cash generated from operating activities. Repurchases will be made through open market transactions, and the amount and timing of purchases will depend on business and market conditions, the stock price, trading restrictions, the level of acquisition activity and other factors.

We have purchased 24.2 million shares since the inception of the program through September 30, 2015. During the nine months ended September 30, 2015 and 2014, we spent $371.2 million and $296.5 million on the repurchase of 1,167,796 shares and 1,186,215 shares at an average price per share of $317.86 and $249.91, respectively. We also reissued 281,627 shares and 246,551 shares held in treasury for the exercise of stock options and restricted stock units during the nine months ended September 30, 2015 and 2014, respectively.

### Effect of Currency on Results of Operations

Our earnings are affected by changing exchange rates. We are most sensitive to changes in the exchange rates between the Swiss franc, euro, and U.S. dollar. We have more Swiss franc expenses than we do Swiss franc sales because we develop and manufacture products in Switzerland that we sell globally, and have a number of corporate functions located in Switzerland. When the Swiss franc strengthens against our other trading currencies, particularly the U.S. dollar and euro, our earnings go down. We also have significantly more sales in the euro than we do expenses. When the euro weakens against the U.S. dollar and Swiss franc, our earnings also go down.

We entered into foreign currency forward contracts that reduce our exposure from the Swiss franc strengthening against the euro through 2016. The notional amount and average forward rate of our foreign currency forward contracts at September 30, 2015 is Euro 26.7 million and 1.20 for contracts that mature in 2015, and Euro 66.5 million and 1.19 for contracts that mature in 2016, respectively. In September 2011, the Swiss National Bank established an exchange rate floor of 1.2 Swiss francs per euro which was abandoned in January 2015 after we entered into the previously mentioned foreign currency forward contracts. The Swiss National Bank's abandonment of the euro exchange rate floor resulted in an immediate strengthening of the Swiss franc against the euro and U.S. dollar. Absent these forward currency contracts, we estimate a 1% strengthening of the Swiss franc against the euro would reduce our earnings before tax by approximately $1.1 million to $1.3 million annually. We also estimate a 1% strengthening of the Swiss franc against the U.S. dollar would reduce our earnings before tax by approximately $0.5 million to $0.7 million annually in addition to the previously mentioned strengthening of the Swiss franc against the euro impact.

We also conduct business in many geographies throughout the world, including Asia Pacific, the United Kingdom, Eastern Europe, Latin America, and Canada. Fluctuations in these currency exchange rates against the U.S. dollar can also affect our operating results. The most significant of these currency exposures is the Chinese Renminbi. The impact on our earnings before tax of the Chinese Renminbi weakening 1% against the U.S. dollar is a reduction of approximately $0.7 million to $0.9 million annually.

In addition to the effects of exchange rate movements on operating profits, our debt levels can fluctuate due to changes in exchange rates, particularly between the U.S. dollar and the Euro. Based on our outstanding debt at September 30, 2015, we estimate that a 10% weakening of the U.S. dollar against the currencies in which our debt is denominated would result in an increase of approximately $19.2 million in the reported U.S. dollar value of our debt.

### Recent Accounting Pronouncements

In April 2015, the FASB issued ASU 2015-03, to ASC 835-30 "Interest - Imputation of Interest." ASU 2015-03 will require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this update. In August 2015, the FASB issued ASU 2015-15 and update to ASU 2015-03, which addresses the accounting for debt issuance costs related to line-of-credit arrangements as an asset and subsequently amortized over the term of the arrangements. The guidance becomes effective for financial statements issued for fiscal years beginning January 1, 2016, with early adoption permitted. We do not believe the adoption of this guidance will have a material impact on the consolidated financial position of the Company.

In May 2014, the FASB issued ASU 2014-09, to ASC 606 "Revenue from Contracts with Customers." ASU 2014-09 provides authoritative guidance clarifying the principles for recognizing revenue and developing a common revenue standard for U.S. GAAP. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. Additionally, the guidance requires improved disclosure to help users of financial statements better understand the nature, amount, timing and uncertainty of revenue that is recognized. The guidance becomes effective for the Company for the year beginning January 1, 2018. We are currently evaluating the impact the adoption of this guidance will have on the consolidated results of operations, financial position and disclosures.

### Forward-Looking Statements Disclaimer

*You should not rely on forward-looking statements to predict our actual results. Our actual results or performance may be materially different than reflected in forward-looking statements because of various risks and uncertainties. You can identify forward-looking statements by terminology such as “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “potential” or “continue”.*

*We make forward-looking statements about future events or our future financial performance, including earnings and sales growth, earnings per share, strategic plans and contingency plans, growth opportunities or economic downturns, our ability to respond to changes in market conditions, planned research and development efforts and product introductions, adequacy of facilities, access to and the costs of raw materials, shipping and supplier costs, gross margins, customer demand, our competitive position , capital expenditures, cash flow, tax-related matters, compliance with laws, and effects of acquisitions.*

*Our forward-looking statements may not be accurate or complete, and we do not intend to update or revise them in light of actual results. New risks also periodically arise. Please consider the risks and factors that could cause our results to differ materially from what is described in our forward-looking statements. See in particular “Factors Affecting Our Future Operating Results” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our 2014 Annual Report on Form 10-K.*

## Market risk

As filed, 178 characters.

As of September 30, 2015, there was no material change in the information provided under Item 7A in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014.

## Controls and procedures

As filed, 781 characters.

Under the supervision and with the participation of our management, including the Chief Executive Officer, Principal Financial Officer and the Principal Accounting Officer, we have evaluated the effectiveness of our disclosure controls and procedures as required by Exchange Act Rule 13a-15(b) as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer, Principal Financial Officer, and Principal Accounting Officer, have concluded that these disclosure controls and procedures are effective. There were no changes in our internal control over financial reporting during the quarter ended September 30, 2015 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 204 characters.

For the nine months ended September 30, 2015 there were no material changes from risk factors disclosed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2014.

Filed Nov 6, 2015.
Source: SEC EDGAR, the filing index for accession 0001037646-15-000034. Last ingested by Listed: Nov 13, 2026, 02:43 ET. No prices; not investment advice.
